Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TB CHAMP trial
ISRCTN92634082Phase 3Completed
- Sponsor
- Stellenbosch University
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multidrug-resistant tuberculosis (MDR-TB) comparing Levofloxacin with Placebo (2 arms). Primary endpoint: Incident tuberculosis disease including tuberculosis death by 48 weeks post-randomization. Started Oct 2016; status: completed.
02
Drugs
levofloxacin
03
Conditions
multidrug-resistant tuberculosis (MDR-TB)
Beyond the preview
Go deeper on ISRCTN92634082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN92634082.